Seres Therapeutics Inc (MCRB) — Working Capital to Net Assets Ratio
Seres Therapeutics Inc (MCRB) has a Working Capital to Net Assets ratio of 47.1% as of March 2026. Working capital of $12.49 Million (current assets of $31.84 Million minus current liabilities of $19.34 Million) is measured against net assets of $26.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MCRB financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Seres Therapeutics Inc Working Capital to Net Assets (2012–2025)
This chart shows how Seres Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 47.1%, reflecting working capital of $12.49 Million against net assets of $26.50 Million USD. See Seres Therapeutics Inc (MCRB) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Seres Therapeutics Inc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Seres Therapeutics Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see MCRB market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 68.0% | $30.05 Million | $44.22 Million | $49.38 Million | $19.32 Million | ▲ +86.5 pp |
| 2024 | -18.5% | $-2.55 Million | $13.78 Million | $38.67 Million | $41.22 Million | ▲ +152.6 pp |
| 2023 | -171.1% | $76.75 Million | $-44.86 Million | $175.41 Million | $98.66 Million | ▼ -1183.5 pp |
| 2022 | 1012.4% | $109.17 Million | $10.78 Million | $194.76 Million | $85.60 Million | ▲ +844.1 pp |
| 2021 | 168.3% | $221.37 Million | $131.51 Million | $303.63 Million | $82.26 Million | ▲ +41.1 pp |
| 2020 | 127.2% | $222.36 Million | $174.75 Million | $268.78 Million | $46.41 Million | ▲ +239.4 pp |
| 2019 | -112.2% | $54.20 Million | $-48.32 Million | $100.19 Million | $45.99 Million | ▼ -6.8 pp |
| 2018 | -105.4% | $50.62 Million | $-48.05 Million | $92.67 Million | $42.04 Million | ▼ -308.8 pp |
| 2017 | 203.4% | $123.45 Million | $60.70 Million | $155.08 Million | $31.62 Million | ▲ +76.8 pp |
| 2016 | 126.6% | $167.91 Million | $132.63 Million | $198.37 Million | $30.46 Million | ▲ +30.8 pp |
| 2015 | 95.8% | $196.69 Million | $205.39 Million | $207.61 Million | $10.92 Million | ▲ +504.2 pp |
| 2014 | -408.4% | $109.14 Million | $-26.72 Million | $114.24 Million | $5.10 Million | ▼ -511.3 pp |
| 2013 | 102.9% | $649.00K | $631.00K | $1.71 Million | $1.06 Million | ▲ +7.5 pp |
| 2012 | 95.4% | $6.07 Million | $6.36 Million | $6.25 Million | $178.00K | — |